979 related articles for article (PubMed ID: 28615077)
1. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
2. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L
Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of harm reduction.
Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
[TBL] [Abstract][Full Text] [Related]
4. Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria.
Nishimoto L; Ikani P; Achanya J; Idowu A; Olisa AL; Walker CF; Gottlieb A; Akolo C
Glob Health Sci Pract; 2023 Feb; 11(1):. PubMed ID: 36853631
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China.
Yang Y; Latkin CA; Luan R; Yang C
BMC Public Health; 2015 Sep; 15():885. PubMed ID: 26370245
[TBL] [Abstract][Full Text] [Related]
6. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P
J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812
[TBL] [Abstract][Full Text] [Related]
7. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
[TBL] [Abstract][Full Text] [Related]
8. Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces.
Wang K; Fu H; Longfield K; Modi S; Mundy G; Firestone R
Harm Reduct J; 2014 May; 11():15. PubMed ID: 24885778
[TBL] [Abstract][Full Text] [Related]
9. An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.
Goswami P; Medhi GK; Armstrong G; Setia MS; Mathew S; Thongamba G; Ramakrishnan L; George B; Singh RK; Paranjape RS; Mahanta J
Int J Drug Policy; 2014 Sep; 25(5):853-64. PubMed ID: 24925819
[TBL] [Abstract][Full Text] [Related]
10. Injection network drivers of HIV prevention service utilization among people who inject drugs: results of a community-based sociometric network cohort in New Delhi, India.
Prata Menezes NS; Mehta SH; Wesolowski A; Clipman SJ; Srikrishnan AK; Kumar MS; Zook KJC; Lucas GM; Latkin C; Solomon SS
J Int AIDS Soc; 2024 Apr; 27(4):e26241. PubMed ID: 38632848
[TBL] [Abstract][Full Text] [Related]
11. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
12. "Until people start dying in droves, no actions will be taken": perception and experience of HIV-preventive measures among people who inject drugs in northwestern Russia.
Meylakhs P; Aasland A; Grønningsæter A
Harm Reduct J; 2017 Jun; 14(1):33. PubMed ID: 28583120
[TBL] [Abstract][Full Text] [Related]
13. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N;
AIDS Care; 2016 Oct; 28(10):1312-5. PubMed ID: 27178119
[TBL] [Abstract][Full Text] [Related]
14. Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India.
Prata Menezes N; Mehta SH; Wesolowski A; Clipman SJ; Srikrishnan AK; Kumar MS; Zook KJC; Lucas GM; Latkin C; Solomon SS
Addiction; 2024 Mar; 119(3):570-581. PubMed ID: 37967827
[TBL] [Abstract][Full Text] [Related]
15. Overlap between harm reduction and HIV service utilisation among PWID in India: Implications for HIV combination prevention.
Smith MK; Solomon SS; Cummings DAT; Srikrishnan AK; Kumar MS; Vasudevan CK; McFall AM; Lucas GM; Celentano DD; Mehta SH
Int J Drug Policy; 2018 Jul; 57():111-118. PubMed ID: 29730586
[TBL] [Abstract][Full Text] [Related]
16. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
[TBL] [Abstract][Full Text] [Related]
17. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
Bruggmann P; Grebely J
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis.
Cepeda JA; Burgos JL; Kahn JG; Padilla R; Meza Martinez PE; Segovia LA; Gaines T; Abramovitz D; Rangel G; Magis-Rodriguez C; Vickerman P; Strathdee SA; Martin NK
BMJ Open; 2019 Jan; 9(1):e026298. PubMed ID: 30700490
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature.
Grenfell P; Baptista Leite R; Garfein R; de Lussigny S; Platt L; Rhodes T
Drug Alcohol Depend; 2013 May; 129(3):180-209. PubMed ID: 23306095
[TBL] [Abstract][Full Text] [Related]
20. Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto Rico.
Welch-Lazoritz M; Habecker P; Dombrowski K; Rivera Villegas A; Davila CA; Rolón Colón Y; Miranda De León S
Int J Drug Policy; 2017 May; 43():16-22. PubMed ID: 28160735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
